Find a Clinician

Close
David A.  Williams

David A. Williams, MD

LIke ThisLIke ThisLIke ThisLIke ThisLIke This
Associate Chair, Pediatric Oncology, Dana-Farber Cancer Institute; Chief, Division of Hematology/Oncology; Director of Translational Research, Children's Hospital BostonLeland Fikes Professor of Pediatrics, Harvard Medical School
Primary Office Location: Boston Children's HospitalHematologyKarp Family Research Laboratories1 Blackfan Circle, 8th FloorBoston, Massachusetts 02115

Contact: 617-355-8246

Fax: 617-730-0641

Appointments:617-355-8246

Get Directions
Email this person
Send an email to SendYour Name*Your Email Address*Subject*Comments*
    • Departments/Divisions
    • Hematology / Oncology
    • Medicine
    • Services/Programs
    • Bone Marrow Failure Program
    • Myelodysplastic Syndrome Specialty Program
    • Hematology / Oncology
  • Fanconi Anemia and Other Genetic Disorders

    Viral Vectors

    Blood Formation

    Hematopoiesis

    Gene Therapy

    Aplastic Anemia

    Chronic Granulomatous Disease

  • Medicine

    Indiana University School of Medicine, 1979

    Indianapolis, IN

    Pediatrics

    Cincinnati's Children's Hospital Medical Center, 1980

    Cincinnati, OH

    Pediatrics

    Cincinnati's Children's Hospital Medical Center, 1982

    Cincinnati, OH

    Hematology/Oncology

    Boston Children's Hospital/Dana-Farber Cancer Institute, 1985

    Boston, MA

  • Pediatrics

  • Dr. Williams major research interests are in the study of blood stem cell biology, blood formation, leukemia and the treatment of genetic blood diseases using gene therapy. He has published over 250 peer-reviewed manuscripts and textbook chapters. He was an investigator of the HHMI for 16 years. He has been continuously funded by the NIH since 1986. His laboratory co-discovered and cloned Interleukin-11 (Neumega TM) and carried out developmental studies that assisted in obtaining FDA approval of this drug. His laboratory also described and patented the use of fibronectin in retrovirus-mediated gene transfer, now nearly universally used (as Retronectin TM) in clinical gene therapy trials and basic research utilizing gene transfer. His most recent focus has been on exploring the role of Rho GTPases in hematopoietic stem cell biology. He and Dr. Yi Zheng have developed a new small molecule inhibitor of Rac GTPases that is being investigated collaboratively in cancer therapies. Thus, work in the Williams laboratory has led to multiple patents and product licenses for new therapies in human diseases. He also leads several gene therapy trials in immunodeficiency and neurologic disease.

Close
Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
close
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
BrowseSearch
Condition & Treatments
Search for a Condition or Treatment:
Show Items Starting With: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
View allSearch
Locations

Locations for this Clinician

map
  • map
  • marker
    Boston Children's HospitalHematologyKarp Family Research Laboratories1 Blackfan Circle, 8th FloorBoston, Massachusetts 02115
    Appointments:
    617-355-8246
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close